Zealand Pharma A/S/ADR (ZLDPF) research
Zealand Pharma A/S/ADR- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $40.00
- As of
Zealand Pharma A/S/ADR (ZLDPF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.
As of . Source: SEC EDGAR filings for ZLDPF. Method and limitations.
Share the ZLDPF intelligence card
See the full ZLDPF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ZLDPF on one page. Preview it with sample data, then open it live with a free account.
Preview the ZLDPF dossierActive signals for ZLDPF
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 5719.0%, EPS $55.7928 vs $0.9588 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 38.2% - EPS $-5.58 vs $-9.029 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 5.5% - EPS $107.61 vs $113.9187 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 30.4% - EPS $-5.75 vs $-8.2609 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 86.6% - EPS $-1.11 vs $-8.2852 estimate
FREE, NO ACCOUNT
Every signal on ZLDPF, as it fires
You are seeing 5 of 6 signals recorded on ZLDPF since 2026-05-31.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Related tickers
See more ZLDPF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ZLDPFand get the insider, 13F, options, and confluence read in one view.